Osteoporosis, osteopenia, and inflammatory bowel disease: lessons from a real-world study

被引：4
|
作者：
Pellicano, Rinaldo [1 ]
Ribaldone, Davide G. [2 ]
机构：
[1] Molinette SGAS Hosp, Unit Gastroenterol, Turin, Italy
[2] Univ Turin, Div Gastroenterol, Dept Med Sci, Turin, Italy
来源：
POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ | 2018年 / 128卷 / 7-8期
关键词：
CROHNS-DISEASE; FRACTURE RISK; DENSITY; CALCIUM;
D O I：
10.20452/pamw.4325
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：411 / 413
页数：3
相关论文
共 50 条
  • [1] Adalimumab Persistence and Its Biosimilar in Inflammatory Bowel Disease: A Real-World Study
    Fernandez-Cano, Maria Carmen
    Fernandez-Cano, Antonio Jesus
    Martin-Rodriguez, Maria Mar
    Sanchez-Capilla, Antonio Damian
    Cabello-Tapia, Maria Jose
    Redondo-Cerezo, Eduardo
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (02)
  • [2] Osteopenia and osteoporosis in patients with new diagnosis of inflammatory bowel disease
    Adriani, A.
    Pantaleoni, S.
    Luchino, M.
    Ribaldone, D. G.
    Reggiani, S.
    Sapone, N.
    Sguazzini, C.
    Isaia, G.
    Pellicano, R.
    Astegiano, M.
    PANMINERVA MEDICA, 2014, 56 (02) : 145 - 149
  • [3] Corticosteroid-induced osteoporosis and osteopenia in inflammatory bowel disease
    Firouzi, F
    Zali, MR
    Bahari, A
    Daryani, NE
    Aghazadeh, R
    Emam, MM
    Shalmani, HM
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (09): : S309 - S309
  • [4] Pregnancy in Inflammatory Bowel Disease: Data from a Real-World Cohort in Germany
    Ayoub, Mousa
    Muzalyova, Anna
    Ebigbo, Alanna
    Nagl, Sandra
    Roemmele, Christoph
    Classen, Johanna
    Wanzl, Julia
    Fleischmann, Carola
    Ayoub, Sami
    Tadic, Vidan
    Schlottmann, Jakob
    Schnoy, Elisabeth
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (24)
  • [5] Real-World Persistence of Ustekinumab in the Treatment of Inflammatory Bowel Disease
    Brian Bressler
    Jennifer Jones
    Tracy S. H. In
    Tommy Lan
    Cristian Iconaru
    John K. Marshall
    Advances in Therapy, 2023, 40 : 4421 - 4439
  • [6] Real-World Persistence of Ustekinumab in the Treatment of Inflammatory Bowel Disease
    Bressler, Brian
    Jones, Jennifer
    In, Tracy S. H.
    Lan, Tommy
    Iconaru, Cristian
    Marshall, John K.
    ADVANCES IN THERAPY, 2023, 40 (10) : 4421 - 4439
  • [7] How to Optimize Treatment With Ustekinumab in Inflammatory Bowel Disease: Lessons Learned From Clinical Trials and Real-World Data
    Gutierrez, Ana
    Rodriguez-Lago, Iago
    FRONTIERS IN MEDICINE, 2021, 8
  • [8] Vedolizumab clearance as a predictor of remission in inflammatory bowel disease: a real-world pharmacokinetic study
    Markovic, S.
    Kralj, D.
    Ivanovski, T. Knezevic
    Kalaba, A.
    Odanovic, O.
    Homsek, A.
    Svorcan, P.
    Vucicevic, K.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : I1231 - I1231
  • [9] Osteoporosis and Osteopenia in Patients with Inflammatory Bowel Diseases
    Bodryagina, Evgenia Sergeevna
    Abdulganieva, Diana Ildarovna
    Odintsova, Alfia Kharisovna
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (04) : S87 - S87
  • [10] Facing Real-World Challenges of Immunogenicity in Pediatric Inflammatory Bowel Disease
    Gress, Kyle
    Bass, Julie A.
    Funk, Ryan S.
    Morrow, Ryan P.
    Hasenkamp, Rachel
    Shakhnovich, Valentina
    FRONTIERS IN IMMUNOLOGY, 2020, 11
12345